February 5, 2014
Stories this photo appears in:
San Diego-based aTyr Pharma Inc. reported a net loss of $9.1 million for the first quarter of 2015, up from a net loss of $6.2 million in the same period last year.
ATyr Pharma Inc. is planning to raise approximately $76 million in an IPO May 7th.
ATyr Pharma Inc., a company that treats diseases of the immune system, has appointed biotech veteran David Weiner as its chief medical officer.
San Diego-based aTyr Pharma named Frederic Chereau president and chief operating officer.